Baldwin Wealth Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Baldwin Wealth Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1	Closed	-$23	–	1081
2024 Q2	$23	Buy	+1	New	+$25	﹤0.01%	788
2023 Q4	–	Sell	-30	Closed	-$836	–	729
2023 Q3	$836	Hold	30	–	–	﹤0.01%	710
2023 Q2	$1.02K	Hold	30	–	–	﹤0.01%	717
2023 Q1	$902	Hold	30	–	–	﹤0.01%	760
2022 Q4	$847	Hold	30	–	–	﹤0.01%	747
2022 Q3	$1K	Hold	30	–	–	﹤0.01%	628
2022 Q2	$1K	Hold	30	–	–	﹤0.01%	659
2022 Q1	$1K	Hold	30	–	–	﹤0.01%	648
2021 Q4	$2K	Hold	30	–	–	﹤0.01%	597
2021 Q3	$2K	Hold	30	–	–	﹤0.01%	615
2021 Q2	$3K	Hold	30	–	–	﹤0.01%	605
2021 Q1	$3K	Sell	30 -620	-95%	-$61.5K	﹤0.01%	579
2020 Q4	$61K	Buy	650 +620	+2,067%	+$49.4K	0.01%	300
2020 Q3	$2K	Hold	30	–	–	﹤0.01%	503
2020 Q2	$2K	Hold	30	–	–	﹤0.01%	504
2020 Q1	$1K	Buy	+30	New	+$1K	﹤0.01%	527

Other funds holding ARKG

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Baldwin Wealth Partners's ARKG Position: Q3 2024 in Review

Baldwin Wealth Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 1 share — an estimated $23 sold.

Baldwin Wealth Partners first reported a position in ARKG in Q1 2020 and held it in 16 quarters. The position peaked at $61K in Q4 2020. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

Baldwin Wealth Partners reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
Baldwin Wealth Partners sold 1 ARK Genomic Revolution ETF share in Q3 2024, an estimated $23.
Baldwin Wealth Partners first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 16 quarters.
Baldwin Wealth Partners's ARK Genomic Revolution ETF position peaked at $61K in Q4 2020.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Baldwin Wealth Partners's 13F filing for Q3 2024, filed 16 Oct 2024.